NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis → America’s worst nightmare? (From Porter & Company) (Ad) Free LFST Stock Alerts $7.37 +0.20 (+2.79%) (As of 01:44 PM ET) Add Compare Share Share Today's Range$7.16▼$7.4450-Day Range$5.62▼$7.3852-Week Range$4.74▼$9.59Volume458,825 shsAverage Volume1.28 million shsMarket Capitalization$2.82 billionP/E RatioN/ADividend YieldN/APrice Target$8.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get LifeStance Health Group alerts: Email Address LifeStance Health Group MarketRank™ Stock AnalysisAnalyst RatingHold2.17 Rating ScoreUpside/Downside20.8% Upside$8.83 Price TargetShort InterestBearish22.44% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.41Based on 12 Articles This WeekInsider TradingSelling Shares$1.79 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.30) to ($0.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.59 out of 5 starsMedical Sector2622nd out of 2,771 stocksHealth Services Industry25th out of 30 stocks 2.1 Analyst's Opinion Consensus RatingLifeStance Health Group has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 2 buy ratings, 3 hold ratings, and 1 sell rating.Amount of Analyst CoverageLifeStance Health Group has only been the subject of 4 research reports in the past 90 days.Read more about LifeStance Health Group's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted22.44% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 15.7, which indicates bearish sentiment.Change versus previous monthShort interest in LifeStance Health Group has recently increased by 3.75%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LFST. Previous Next 2.4 News and Social Media Coverage News SentimentLifeStance Health Group has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for LifeStance Health Group this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.MarketBeat Follows3 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,786,868.00 in company stock.Percentage Held by InsidersOnly 6.60% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for LifeStance Health Group are expected to grow in the coming year, from ($0.30) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is -15.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is -15.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LifeStance Health Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingThe World’s Richest Man Blindsided by AIThese billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you.Get the full story here. About LifeStance Health Group Stock (NASDAQ:LFST)LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Read More LFST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LFST Stock News HeadlinesApril 20, 2024 | insidertrades.comInsider Selling: LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells 12,965 Shares of StockMay 13 at 7:17 PM | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2024 Earnings Call TranscriptMay 12 at 10:12 AM | finance.yahoo.comEarnings Update: Here's Why Analysts Just Lifted Their LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target To US$8.79May 10, 2024 | markets.businessinsider.comBarclays Reaffirms Their Sell Rating on Lifestance Health Group (LFST)May 10, 2024 | finance.yahoo.comLifeStance Health Group Inc (LFST) Q1 2024 Earnings: Misses on Revenue, Narrows Net LossMay 9, 2024 | finanznachrichten.deLifeStance Health Group, Inc.: LifeStance Reports First Quarter 2024 ResultsMay 9, 2024 | msn.comLifeStance Health Group GAAP EPS of -$0.06, revenue of $300.4MMay 9, 2024 | globenewswire.comLifeStance Reports First Quarter 2024 ResultsMay 1, 2024 | prnewswire.comLifeStance Destigmatizes Mental Health in Newest "Not One Face" Campaign Featuring Photography from Leica AmbassadorsApril 30, 2024 | markets.businessinsider.comLifeist Announces Common Share ConsolidationApril 28, 2024 | nasdaq.comCommit To Purchase LifeStance Health Group At $4, Earn 13.7% Annualized Using OptionsApril 27, 2024 | nasdaq.comLifeStance Health Group, Inc. Common Stock (LFST)April 20, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (LFST)April 18, 2024 | globenewswire.comLifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024April 12, 2024 | finance.yahoo.comAt US$6.13, Is It Time To Put LifeStance Health Group, Inc. (NASDAQ:LFST) On Your Watch List?April 2, 2024 | benzinga.comLifeist Reports Highest Quarterly Gross Profit In History, Continues To Diversify Its Wellness BusinessApril 2, 2024 | markets.businessinsider.comLifeist Reports Fourth Quarter 2023 Financial ResultsMarch 20, 2024 | investing.comLifeStance Health executive sells over $280k in company stockMarch 20, 2024 | markets.businessinsider.comLifeist Announces Results of Annual General and Special Meeting of ShareholdersMarch 13, 2024 | investing.comLifestance Health Group Inc (LFST)March 12, 2024 | finance.yahoo.comLifeStance Appoints Dr. Teresa DeLuca to Board of DirectorsMarch 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFSTMarch 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFSTMarch 2, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported And Analysts Have Been Lifting Their Price TargetsMarch 1, 2024 | seekingalpha.comLifeStance Health Group, Inc. (LFST) Q4 2023 Earnings Call TranscriptSee More Headlines Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today5/14/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:LFST CUSIPN/A CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees9,325Year FoundedN/APrice Target and Rating Average Stock Price Target$8.83 High Stock Price Target$10.00 Low Stock Price Target$8.00 Potential Upside/Downside+23.2%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-186,260,000.00 Net Margins-15.69% Pretax Margin-17.13% Return on Equity-11.92% Return on Assets-8.09% Debt Debt-to-Equity Ratio0.20 Current Ratio1.18 Quick Ratio1.18 Sales & Book Value Annual Sales$1.06 billion Price / Sales2.60 Cash FlowN/A Price / Cash FlowN/A Book Value$3.77 per share Price / Book1.90Miscellaneous Outstanding Shares382,290,000Free Float357,057,000Market Cap$2.74 billion OptionableOptionable Beta1.29 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Kenneth Alan Burdick (Age 65)CEO & Chairman Comp: $624.22kMr. Danish J. Qureshi (Age 39)President & COO Comp: $342.2kMr. David Patrick Bourdon (Age 54)Chief Financial Officer & Treasurer Comp: $368.6kMs. Monica ProkockiVice President of Investor RelationsMr. Ryan Pardo (Age 48)Chief Legal Officer & Secretary Brooke MatthewsDirector of Public RelationsMs. Ann Varanakis (Age 46)Chief People Officer Mr. Pablo Pantaleoni (Age 36)Chief Digital Officer Mr. Kevin Michael Mullins (Age 39)Chief Development Officer Ms. Paula WoodChief Business Transformation OfficerMore ExecutivesKey CompetitorsMagellan HealthNASDAQ:MGLNApollo MedicalNASDAQ:AMEHPrivia Health GroupNASDAQ:PRVAProgynyNASDAQ:PGNY1Life HealthcareNASDAQ:ONEMView All CompetitorsInsiders & InstitutionsBessemer Group Inc.Bought 2,768 shares on 5/13/2024Ownership: 0.002%Vanguard Group Inc.Bought 95,197 shares on 5/10/2024Ownership: 2.006%ProShare Advisors LLCBought 1,500 shares on 5/8/2024Ownership: 0.005%SG Americas Securities LLCBought 3,600 shares on 5/7/2024Ownership: 0.012%Allen Investment Management LLCBought 12,873 shares on 5/7/2024Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions LFST Stock Analysis - Frequently Asked Questions Should I buy or sell LifeStance Health Group stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" LFST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LFST, but not buy additional shares or sell existing shares. View LFST analyst ratings or view top-rated stocks. What is LifeStance Health Group's stock price target for 2024? 6 brokerages have issued 1 year price objectives for LifeStance Health Group's shares. Their LFST share price targets range from $8.00 to $10.00. On average, they expect the company's share price to reach $8.83 in the next twelve months. This suggests a possible upside of 20.8% from the stock's current price. View analysts price targets for LFST or view top-rated stocks among Wall Street analysts. How have LFST shares performed in 2024? LifeStance Health Group's stock was trading at $7.83 at the beginning of 2024. Since then, LFST shares have decreased by 6.6% and is now trading at $7.31. View the best growth stocks for 2024 here. When is LifeStance Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our LFST earnings forecast. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) released its quarterly earnings data on Thursday, May, 9th. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.03. The firm had revenue of $300.44 million for the quarter, compared to analysts' expectations of $299.02 million. LifeStance Health Group had a negative net margin of 15.69% and a negative trailing twelve-month return on equity of 11.92%. LifeStance Health Group's revenue for the quarter was up 18.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.09) EPS. What ETFs hold LifeStance Health Group's stock? ETFs with the largest weight of LifeStance Health Group (NASDAQ:LFST) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), SPDR S&P Health Care Services ETF (XHS) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has LifeStance Health Group issued on next quarter's earnings? LifeStance Health Group issued an update on its second quarter 2024 earnings guidance on Thursday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $297.0 million-$315.0 million, compared to the consensus revenue estimate of $305.0 million. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an initial public offering (IPO) on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.01%), Principal Financial Group Inc. (1.04%), Jennison Associates LLC (0.51%), O Brien Wealth Partners LLC (0.14%), Hemington Wealth Management (0.10%) and Swiss National Bank (0.05%). Insiders that own company stock include Anisha Patel-Dunn, Ann Varanakis, Danish J Qureshi, David Bourdon, Gwen H Booth, Jeffrey Crisan, Jesse Michael Bruff, Kenneth T Mills, Kevin Michael Mullins, Michael K Lester, Paula Cipollone, Ryan Pardo, Silversmith Partners I Gp, Llc, Summit Partners Growth Equity and Warren Gouk. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:LFST) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.